MINT-AMOXI/CLAV 125 MG — DIN 02513250
CLAVULANIC ACID (CLAVULANATE POTASSIUM) : 125 MG AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 250 MG · MINT PHARMACEUTICALS INC · TABLET · wholesale supply in Canada
Health Canada status: APPROVED
What is MINT-AMOXI/CLAV?
MINT-AMOXI/CLAV 125 MG contains CLAVULANIC ACID (CLAVULANATE POTASSIUM) : 125 MG AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02513250, held by MINT PHARMACEUTICALS INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 04-Mar-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Amoxicillin And Beta-Lactamase Inhibitor cost around the world?
Amoxicillin And Beta-Lactamase Inhibitor is listed on 15 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 153 | 166 | SAR███.██ |
| Australia | ex-manufacturer | 34 | 132 | AUD███.██ |
| South Africa | single exit price | 96 | 122 | ZAR███.██ |
| United States | acquisition | 10 | 98 | USD███.██ |
| Bahrain | retail (max) | 36 | 93 | BHD███.██ |
| Czechia | max producer price (ex-factory) | 15 | 41 | CZK███.██ |
| Romania | max producer price | 25 | 41 | RON███.██ |
| Sweden | AIP (pharmacy purchase price) | 14 | 38 | SEK███.██ |
| Austria | KVP (Kassenverkaufspreis) | 18 | 32 | EUR███.██ |
| United Kingdom | hospital | 15 | 15 | GBP███.██ |
| Luxembourg | reimbursement | 9 | 9 | EUR███.██ |
| Iceland | max wholesale | 3 | 5 | ISK███.██ |
| Greece | producer price (ex-factory) | 4 | 4 | EUR███.██ |
| Hungary | producer price (ex-factory) | 3 | 3 | HUF███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
800 pack listings across 436 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every Amoxicillin And Beta-Lactamase Inhibitor pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Amoxicillin And Beta-Lactamase Inhibitor in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
14 holders have a Canadian DIN containing Amoxicillin And Beta-Lactamase Inhibitor, across 59 DINs, of which 28 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| JAMP PHARMA CORPORATION | 6 | 5 | JAMP AMOXI CLAV, JAMP AMOXI CLAV SUSPENSION | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 5 | 5 | AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION, SANDOZ AMOXI-CLAV TABLET | Sourceable in Canada |
| GLAXOSMITHKLINE INC | 7 | 4 | CLAVULIN 125 F ORAL SUS, CLAVULIN 200, CLAVULIN 250 F ORAL SUS, CLAVULIN 250 TAB, CLAVULIN 400, +2 more | Sourceable in Canada |
| APOTEX INC | 9 | 3 | APO-AMOXI CLAV, APO-AMOXI CLAV 125MG/31.25MG PER 5ML, APO-AMOXI CLAV 250MG/62.5MG PER 5ML, APO-AMOXICILLIN-CLAVULANATE | Sourceable in Canada |
| AURO PHARMA INC | 3 | 3 | AURO-AMOXICLAV | Sourceable in Canada |
| ANGITA PHARMA INC. | 6 | 2 | AG-AMOXI CLAV, AG-AMOXI CLAV SUSPENSION | Sourceable in Canada |
| PRO DOC LIMITEE | 5 | 2 | AMOXI-CLAV, PRO-AMOXI CLAV | Sourceable in Canada |
| MANTRA PHARMA INC | 2 | 2 | M-AMOXI CLAV | Sourceable in Canada |
| SANIS HEALTH INC | 2 | 2 | AMOXICILLIN/CLAV | Sourceable in Canada |
| TEVA CANADA LIMITED | 4 | 0 | RATIO-ACLAVULANATE, RATIO-ACLAVULANATE 125 F, RATIO-ACLAVULANATE 250 F | No marketed DIN |
| NOVOPHARM LIMITED | 3 | 0 | NOVO-CLAVAMOXIN 125, NOVO-CLAVAMOXIN 250, NOVO-CLAVAMOXIN 875 | No marketed DIN |
| PHARMASCIENCE INC | 3 | 0 | PMS-AMCLAV-200, PMS-AMCLAV-400, PMS-AMCLAV-875 | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 125 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Amoxicillin And Beta-Lactamase Inhibitor |
|---|---|
| ATC code | J01CR02 |
| AHFS class | 08:12.16.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02513250 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2513250 |
| Brand name | MINT-AMOXI/CLAV |
| Generic / active ingredient | CLAVULANIC ACID (CLAVULANATE POTASSIUM) : 125 MG AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 250 MG |
| Market authorization holder | MINT PHARMACEUTICALS INC |
| Health Canada schedule | Prescription |
| ATC code | J01CR02 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01CR |
| Current status | APPROVED |
| Status date | 04-Mar-2021 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Amoxicillin And Beta-Lactamase Inhibitor in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
28 of 59 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-AMOXI CLAV | 500 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02510634 |
| AG-AMOXI CLAV | 875 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02510642 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02495910 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 2000 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02495937 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 1000 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02495929 |
| AMOXICILLIN/CLAV | 500 MG | TABLET | SANIS HEALTH INC | MARKETED | 02536021 |
| AMOXICILLIN/CLAV | 875 MG | TABLET | SANIS HEALTH INC | MARKETED | 02536048 |
| APO-AMOXI CLAV | 125 MG | TABLET | APOTEX INC | MARKETED | 02243350 |
| APO-AMOXI CLAV | 875 MG | TABLET | APOTEX INC | MARKETED | 02245623 |
| APO-AMOXI CLAV | 500 MG | TABLET | APOTEX INC | MARKETED | 02243351 |
2 · Same class — other molecules in ATC J01CR
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Amoxicillin And Beta-Lactamase Inhibitor | AG-AMOXI CLAV · AG-AMOXI CLAV SUSPENSION · AMOXI-CLAV · AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION · +28 more | 59 | 28 | Yes |
| Piperacillin And Beta-Lactamase Inhibitor | JAMP-PIP/TAZ · PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION · PIPERACILLIN AND TAZOBACTAM FOR INJECTION · PIPERACILLIN/TAZOBACTAM FOR INJECTION · +5 more | 52 | 16 | Yes |
| Ticarcillin And Beta-Lactamase Inhibitor | TIMENTIN | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC J01C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| J01CA | Amoxicillin · Ampicillin · Ampicillin, Combinations · Bacampicillin · Piperacillin · +3 more | 201 | 47 |
| J01CF | Beta-Lactamase Resistant Penicillins · Cloxacillin · Flucloxacillin | 42 | 9 |
| J01CE | Benzathine Benzylpenicillin · Benzathine Phenoxymethylpenicillin · Benzylpenicillin · Combinations · Phenoxymethylpenicillin · +1 more | 69 | 4 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is MINT-AMOXI/CLAV called?
The same molecule, Amoxicillin And Beta-Lactamase Inhibitor, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| AUGMENTIN | Latin | Bahrain, Czechia |
| Amoxil | Latin | Australia, Bahrain |
| APO-Amoxycillin | Latin | Australia |
| Amoxycillin Sandoz | Latin | Australia |
| Omacillin | Latin | Bahrain, Saudi Arabia |
| Amimox® | Latin | Sweden |
| Betaklav | Latin | Czechia, Sweden |
| KLAVOX | Latin | Bahrain |
| AMILOXYN | Latin | Australia |
| APX-Amoxicillin/Clavulanic Acid | Latin | Australia |
| Cilamox | Latin | Australia |
| COMOX | Latin | Australia |
| Curam | Latin | Australia, Bahrain |
| AMOXICILLIN-WGR | Latin | Australia |
| MOXICLAV | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.